Molecular Approaches to the Identification of Unculturable Infectious Agents

Emerging Infectious Diseases

Volumn 2, Issue 3, 1996, Pages 159-167

  Gao, Shou Jiang ^a,b   Moore, Patrick S ^a  

^a Och Spine at New York Presbyterian Hospitals

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MOLECULAR BIOLOGY; POLYMERASE CHAIN REACTION; REVIEW;

BACTERIOLOGICAL TECHNIQUES; HUMANS; MOLECULAR BIOLOGY; POLYMERASE CHAIN REACTION;

EID: 0030183395     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0203.960301     Document Type: Review

References (94)

1. Nichol ST, Spiropoulou CF, Morzunov S, et al. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science 1993;262:914-7.
2. Elliott LH, Ksiazek TG, Rollin PE, et al. Isolation of the causative agent of hantavirus pulmonary syndrome. Am J Trop Med Hyg 1994;51:102-8.
3. Beral V, Peterman TA, Berkelman RL, Jaffe HW. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 1990;335:123-8.
4. Beral V, Bull D, Darby S, et al. Risk of Kaposi's sarcoma and sexual practices associated with faecal contact in homosexual or bisexual men with AIDS. Lancet 1992;339:632-5.
5. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994;265:1865-9.
6. Moore PS, Gao S-J, Dominguez G, et al. Primary characterization of a herpesvirus-like agent associated with Kaposi's sarcoma. J Virol 1996;70:549-58.
7. Hill AB. Environment and disease: association or causation? Proc R Soc Med 1965;58:295-300.
8. Evans AS. Causation and disease: a chronological journey. Am J Epidemiol 1978;108:249-58.
9. Fredricks DN, Relman DA. Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates. Clin Microbiol Rev 1996;9:18-33.
10. Lisitsyn N, Lisitsyn N, Wigler M. Cloning the differences between two complex genomes. Science 1993;259:946-51.
11. Lisitsyn NA, Lisitsina NM, Dalbagni G, et al. Comparative genomic analysis of tumors: detection of DNA losses and amplification. Proc Natl Acad Sci USA 1995;92:151-5.
12. Archibald CP, Schechter MT, Craib KJ, et al. Risk factors for Kaposi's sarcoma in the Vancouver Lymphadenopathy-AIDS Study. JAIDS 1990;3 (suppl 1):S18-23.
13. Beral V, Bull D, Jaffe H, et al. Is risk of Kaposi's sarcoma in AIDS patients in Britain increased if sexual partners came from United States or Africa? Br Med J 1991; 302:624-5.
14. Archibald CP, Schechter MT, Le TN, Craib KJP, Montaner JSG, O'Shaughnessy MV. Evidence for a sexually transmitted cofactor for AIDS-related Kaposi's sarcoma in a cohort of homosexual men. Epidemiol 1992;3:203-9.
15. Peterman TA, Jaffe HW, Beral V. Epidemiologic clues to the etiology of Kaposi's sarcoma. AIDS 1993;7:605-11.
16. Harrington DS, Weisenburger DD, Purtilo DT. Epstein-Barr virus-associated lymphoproliferative lesions. Clin Lab Med 1988;8:97-118.
17. Rangan SR, Martin LN, Enright FM, Abee CR. Herpesvirus saimiri-induced lymphoproliferative disease in howler monkeys. J Natl Cancer Inst 1977;59:165-71.
18. Roizman B. New viral footprints in Kaposi's sarcoma. N Engl J Med 1995;332:1227-8.
19. Rady PL, Yen A, Rollefson JL, et al. Herpesvirus-like DNA sequences in non-Kaposi's sarcoma skin lesions of transplant patients. Lancet 1995;345:1339-40.
20. Levy JA. A new human herpesvirus: KSHV or HHV8? Lancet 1995;346:786.
21. Strathdee SA, Veugelers PJ, Moore PS. The epidemiology of HIV-associated Kaposi's sarcoma: the unraveling mystery. AIDS 1995;10(suppl):S51-7.
22. Moore PS, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma lesions from persons with and without HIV infection. N Engl J Med 1995;332:1181-5.
23. Ambroziak JA, Blackbourn DJ, Herndier BG, et al. Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. Science 1995;268:582-3.
24. Collandre H, Ferris S, Grau O, Montagnier L, Blanchard A. Kaposi's sarcoma and new herpesvirus. Lancet 1995;345:1043.
25. Dupin N, Grandadam M, Calvez V, et al, Herpesvirus-like DNA in patients with Mediterranean Kaposi's sarcoma. Lancet 1995;345:761-2.
26. Boshoff C, Schulz TF, Kennedy MM, et al. Kaposi's sarcoma-associated herpes virus (KSHV) infects endothelial and spindle cells. Nature Med 1995;1:1274-8.
27. Chang Y, Ziegler JL, Wabinga H, et al. Kaposi's sarcoma-associated herpesvirus DNA sequences are present in African endemic and AIDS-associated Kaposi's sarcoma. Arch Intern Med 1996;156:202-4.
28. Schalling M, Ekman M, Kaaya EE, Linde A, Bieberfeld P. A role for a new herpesvirus (KSHV) in different forms of Kaposi's sarcoma. Nature Med 1995;1:707-8.
29. Su I-J, Hsu Y-S, Chang Y-C, Wang I-W. Herpesvirus-like DNA sequence in Kaposi's sarcoma from AIDS and non-AIDS patients in Taiwan. Lancet 1995;345:722-3.
30. Whitby D, Howard MR, Tenant-Flowers M, et al. Detection of Kaposi's sarcoma-associated herpesvirus (KSHV) in peripheral blood of HIV-infected individuals predicts progression to Kaposi's sarcoma. Lancet 1995;364:799-802.
31. Moore PS, Kingsley L, Holmberg SD, et al. KSHV infection prior to onset of Kaposi's sarcoma. AIDS 1996;10:175-80.
32. Boshoff C, Whitby D, Hatziionnou T, et al. Kaposi's sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma. Lancet 1995;345:1043-4.
33. Adams V, Kempf W, Schmid M, Müller B, Briner J, Burg G. Absence of herpesvirus-like DNA sequences in skin cancers of non-immunosuppressed patients. Lancet 1995;346:1715.
34. Boshoff C, Talbot S, Kennedy M, et al. New herpesvirus and immunosuppressed skin cancers. Lancet 1996;347:338-9.
35. Lin J-C, Lin S-C, Mar E-C, et al. Is Kaposi's sarcoma-associated herpesvirus detectable in semen of HIV-infected homosexual men? Lancet 1995;346:1601-2.
36. Gupta P, Mandaleshwar DS, Rinaldo C, et al. Detection of Kaposi's sarcoma herpesvirus DNA in semen of homosexual men with Kaposi's sarcoma. AIDS (in press).
37. Biggar RJ, Curtis RE, Cote TR, Rabkin CS, Melbye M. Risk of other cancers following Kaposi's sarcoma: relation to acquired immunodeficiency syndrome. Am J Epidemiol 1994;139:362-8.
38. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences are present in AIDS-related body cavity based lymphomas. N Engl JMed 1995;332:1186-91.
39. Knowles DM, Inghirami G, Ubriaco A, Dalla-Favera R. Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of Epstein-Barr virus. Blood 1989;73:792-9.
40. Nador RG, Cesarman E, Knowles DM, Said JN. Herpes-like DNA sequences in a body-cavity-based lymphoma in an HIV-negative patient. N Engl J Med 1995;333:943.
41. Soulier J, Grollet L, Oskenhendler E, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995;86:1276-80.
42. Cesarman E, Moore PS, Rao PH, Inghirami G, Knowles DM, Chang Y. In vitro establishment and characterization of two AIDS-related lymphoma cell lines containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood 1995;86:2708-14.
43. Renne R, Zhong W, Herndier B, et al. Lytic growth of Kaposi's sarcoma-aasociated herpesvirus (human herpesvirus 8) in culture. Nature Med 1996;2:342-6.
44. Challoner PB, Smith KT, D. PJ, et al. Plaque-associated expression of human herpesvirus 6 in multiple sclerossis. Proc Natl Acad Sci USA 1995;92:7440-4.
45. Kurtzke JF. Some epidemiologic features compatible with an infectious origin for multiple sclerosis. Int Arch Allergy Appl Immunol 1969;36:59-81.
46. Cook SD, Dowling PC. Multiple sclerosis and viruses: an overview. Neurology 1980;30:80-91.
47. Whitaker JN, Kingsbury DW. Viruses and the pathogenesis of multiple sclerosis. Trends Neurosci 1984;7:57-60.
48. Kurtzke JF. Familial incidence and geography in multiple sclerosis. Acta Neurol Scand 1965;41:127-39.
49. Kurtzke JF. On the fine structure of the distribution of multiple sclerosis. Acta Neurol Scand 1967;43:257-82.
50. Kurtzke JF. Geography in multiple sclerosis. J Neurol 1977;215:1-26.
51. Luppi M, Barozzi P, Maiorana A, Marasca R, Torelli G. Human herpesvirus 6 infection in normal human brain tissue. J Infect Dis 1994;169:943-4.
52. Simons JN, Pilot-Matias TJ, Leary TP, et al. Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci USA 1995;92:3401-5.
53. 52b. Simons JN, Leary TP, Dawson GJ, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nature Med 1995;1:564-9.
54. Schlauder GG, Dawson GJ, Simons JN, et al. Molecular and serologic analysis in the transmission of GB hepatitis agents. J Med Virol 1995;46:81-90.
55. Deinhardt F, Holmes AW, Wolfe L, Junge U. Transmission of viral hepatitis to nonhuman primates. Vox Sanguinis 1970;19:261-9.
56. Tabor E, Peterson DA, April M, Seeff LB, Gerety RJ. Transmission of human non-A, non-B hepatitis to chimpanzees following failure to transmit GB agent hepatitis. J Med Virol 1980;5:103-8.
57. Feinstone SM, Alter HJ, Dienes HP, et al. Non-A, non-B hepatitis in chimpanzees and marmosets. J Infect Dis 1981;144:588-98.
58. Karayiannis P, Petrovic LM, Fry M, et al. Studies of GB hepatitis agent in tamarins. Hepatology 1989;9:186-92.
59. Zuckerman AJ. The new GB hepatitis viruses. Lancet 1995;345:1453-4.
60. Relman DA. The identification of uncultured microbial pathogens. J Infect Dis 1993;168:1-8.
61. Relman DA, Loutit JS, Schmidt TM, Falkow S, Tompkins LS. The agent of bacillary angiomatosis: an approach to the identification of uncultured pathogens. N Engl J Med 1990;323:1573-80.
62. Relman DA, Schmidt TM, MacDermott RP, Falkow S. Identification of the uncultured bacillus of Whipple's disease. N Engl J Med 1992;327:293-301.
63. Lane DJ, Stahl DA, Olsen GJ, Heller DJ, Pace NR. Phylogenetic analysis of the genera Thiobacillus and Thiomicrospira by 5S rRNA sequences. J Bacteriol 1985;163:75-81.
64. Stoler MH, Bonfiglio TA, Steigbigel RT, Pereira M. An atypical subcutaneous infection associated with acquired immune deficiency syndrome. Am J Clin Pathol 1983;80:714-8.
65. Angritt P, Tuur SM, Macher AM, et al. Epithelioid angiomatosis in HIV infection: neoplasm or cat-scratch disease? Lancet 1988;1:996.
66. LeBoit PE, Berger TG, Egbert BM, et al. Epithelioid haemangioma-like vascular proliferation in AIDS: manifestation of cat-scratch disease bacillus infection? Lancet 1988;1:960-3.
67. Koehler JE, Quinn FD, Berger TG, LeBoit PE, Tappero JW. Isolation of Rochalimaea species from cutaneous and osseous lesions of bacillary angiomatosis. N Engl J Med 1992;327:1625-31.
68. Slater LN, Welch DF, Hensel D, Coody DW. A newly recognized fastidious gram-negative pathogen as a cause of fever and bacteremia. N Engl J Med 1990;323:1587-93.
69. Regnery RL, Anderson BE, Clarridge JE, Rodriguez-Barradas MC, Jones DC, Carr JH. Characterization of a novel Rochalimaea species, R. henselae sp. nov., isolated from blood of a febrile, human immunodeficiency virus-positive patient. J Clin Microbiol 1992;30:265-74.
70. Regnery RL, Olson JG, Perkins BA, Bibb W. Serological response to "Rochalimaea henselae" antigen in suspected cat-scratch disease. Lancet 1992;339:1443-5.
71. Welch DF, Pickett DA, Slater LN, Steigerwalt AG, Brenner DJ. Rochalimaea henselae sp. nov., a cause of septicemia, bacillary angiomatosis, and parenchymal bacillary peliosis. J Clin Microbiol 1992;30:275-80.
72. Koehler JE, Glaser CA, Tappero JW. Rochalimaea henselae infections: a new zoonosis with the domestic cat as reservoir. JAMA 1994;271:531-5.
73. Regnery RL, Tappero J. Unravelling mysteries associated with cat-scratch disease, bacillary angiomatosis, and related syndromes. EID 1995;1:16-21.
74. Dobbins WO III. Whipple's disease. Springfield, IL: Charles C Thomas, 1987.
75. Chears WCJ, Ashworth CT. Electron microscopic study of the intestinal mucosa in Whipple's disease: demonstration of encapsulated bacilliform bodies in the lesion. Gastroenterology 1961;41:129-38.
76. Wilson KH, Blitchington R, Frothingham R, Wilson JA. Phylogeny of the Whipple's disease-associated bacterium. Lancet 1991;338:474-5.
77. Centers for Disease Control and Prevention. Outbreak of acute illness - southwestern United States. MMWR 1993;42:421-4.
78. Centers for Disease Control and Prevention. Update: outbreak of hantavirus infection - southwestern United States. MMWR 1993;42:441-3.
79. Leduc JW. Epidemiology of Hantaan and related viruses. Lab Anim Sci 1987;37:413-8.
80. Ksiazek TG, Peters CJ, Rollin PE, et al. Identification of a new North American hantavirus that causes acute pulmonary insufficiency. Am J Trop Med Hyg 1995;52:117-23.
81. Zaki SR, Greer PW, Coffield LM, et al. Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. Am J Pathol 1995;146:552-79.
82. Feinstone SM, Kapikian AZ, Purcell RH, Alter HJ, Holland PV. Transfusion-associated hepatitis not due to viral hepatitis type A or B. N Engl J Med 1975;292:767-70.
83. Knodell RG, Conrad ME, Dienstag JL, Bell CJ. Etiological spectrum of post-transfusion hepatitis. Gastroenterology 1975;69:1278-85.
84. Shih JW, Mur JI, Alter HJ. Non-A, non-B hepatitis: advances and unfulfilled expectations of the first decade. Prog Liver Dis 1986;8:433-52.
85. Bradley DW, McCaustland KA, Cook EH, Schable CA, Ebert JW, Maynard JE. Posttransfusion non-A, non-B hepatitis in chimpanzees: physicochemical evidence that the tubule-forming agent is a small, enveloped virus. Gastroenterology 1985;88:773-9.
86. He LF, Alling D, Popkin T, Shapiro M, Alter HJ, Purcell RH. Determining the size of non-A, non-B hepatitis virus by filtration. J Infect Dis 1987;156:636-40.
87. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359-62.
88. Kuo G, Choo QL, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989;244:362-4.
89. Linnen J, Wages Jr J, Zhang-Keck ZY, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996;271:505-8.
90. 88b. Alter HJ. The cloning and clinical implications of HGV and HGBV-C. N Engl J Med 1996;334:1536-7.
91. Graham DY, Markesich DC, Kalter DC, Moss MT, Hermon-Taylor J, El-Zaatari FA. Mycobacterial aetiology of sarcoidosis. Lancet 1992;340:52-3.
92. Rowley AH, Wolinsky SM, Relman DA, et al. Search for highly conserved viral and bacterial nucleic acid sequences corresponding to an etiologic agent of Kawasaki disease. Pediatr Res 1994;36:567-71.
93. Scott JK, Smith GP. Searching for peptide ligands with an epitope library. Science 1990;249:386-90.
94. Barre-Sinoussi F, Chermann JC, Rey F, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983;220:868-71.